Preoperative Hyponatremia And Hypocalcemia Predict Poor Prognosis In Elderly Gastric Cancer Patients

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Nomura S, Sakamoto H, Glenn S, et al. Population health and regional variations of disease burden in Japan, 1990–2015: a systematic subnational analysis for the Global Burden of Disease Study. Lancet. 2015;2017:390.
   Google Scholar
• Pan R, Zhu M, Yu C, et al. Cancer incidence and mortality: A cohort study in China, 2008–2013. Int J Cancer. 2017;141:1315–1323. doi:10.1002/ijc.3082528593646
   PubMed Web of Science ®Google Scholar
• Chen JH, Hsu SN, Huang TC, et al. Prognostic significance of initial serum albumin and 24 hr daily protein excretion before treatment in multiple myeloma. PLoS One. 2015;10:e0128905.26053837
   PubMed Web of Science ®Google Scholar
• Saito Y, Uraoka T, Yamaguchi Y, et al. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc. 2010;72:1217–1225. doi:10.1016/j.gie.2010.08.00421030017
   PubMed Web of Science ®Google Scholar
• Imamura H, Kurokawa Y, Kawada J, et al. Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: results of a randomized controlled trial. World J Surg. 2011;35:625–630. doi:10.1007/s00268-010-0914-521161652
   PubMed Web of Science ®Google Scholar
• Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer. 2013;132:1272–1276. doi:10.1002/ijc.2796523180638
   PubMed Web of Science ®Google Scholar
• Doshi SM, Shah P, Lei X, Lahoti A, Ak S. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. Am J Kidney Dis. 2012;59:222–228. doi:10.1053/j.ajkd.2011.08.02922001181
   PubMed Web of Science ®Google Scholar
• Ingles GAH, Ang JE, Ameratunga M, et al. A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials. Eur J Cancer. 2018;104:32–38. doi:10.1016/j.ejca.2018.08.01930316017
   PubMed Web of Science ®Google Scholar
• National Institute of Cancer. Common Terminology criteria foradverse events (CTCAE). NIH Publ. 2010;2009:0e71. doi:10.1080/00140139.2010.489653
   Google Scholar
• Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018–1026. doi:10.1056/NEJMoa080120918768945
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Claggett B, Assmann SF, et al. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial. Circulation. 2015;131:34–42. doi:10.1161/CIRCULATIONAHA.114.01325525406305
   PubMed Web of Science ®Google Scholar
• Waikar SS, Mount DB, Gc C. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med. 2009;122:857–865. doi:10.1016/j.amjmed.2009.01.02719699382
   PubMed Web of Science ®Google Scholar
• Rosner MH, Ac D. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia. Clin J Am Soc Nephrol. 2012;7:1722–1729. doi:10.2215/CJN.0247031222879438
   PubMed Web of Science ®Google Scholar
• Provisional guidelines on standard international age classifications. Statistical papers, series M. New York, US 1982.
   Google Scholar
• Daniel D, Nicolas D, CJAoS P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213.15273542
   PubMed Web of Science ®Google Scholar
• Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–196. doi:10.1097/SLA.0b013e3181b13ca219638912
   PubMed Web of Science ®Google Scholar
• Rosner MH, Ac D. Electrolyte disorders associated with cancer. Adv Chronic Kidney Dis. 2014;21:7–17. doi:10.1053/j.ackd.2013.05.00524359982
   PubMed Web of Science ®Google Scholar
• Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol. 2013;20:1575–1583. doi:10.1245/s10434-012-2720-923076557
   PubMed Web of Science ®Google Scholar
• Chawla A, Sterns RH, Nigwekar SU, Cappuccio JD. Mortality and serum sodium: do patients die from or with hyponatremia? Clin J Am Soc Nephrol. 2011;6:960–965. doi:10.2215/CJN.1010111021441132
   PubMed Web of Science ®Google Scholar
• Choi JS, Bae EH, Ma SK, Kweon SS, Sw K. Prognostic impact of hyponatraemia in patients with colorectal cancer. Colorectal Dis. 2015;17:409–416. doi:10.1111/codi.1287825524356
   PubMedGoogle Scholar
• Clines GA, Ta G. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer. 2005;12:549–583. doi:10.1677/erc.1.0054316172192
   PubMed Web of Science ®Google Scholar
• Balachandran K, Okines A, Gunapala R, Morganstein D, Popat S. Resolution of severe hyponatraemia is associated with improved survival in patients with cancer. BMC Cancer. 2015;15:163. doi:10.1186/s12885-015-1156-625885450
   PubMed Web of Science ®Google Scholar
• Schrier RW, Sharma S, Shchekochikhin D. Hyponatraemia: more than just a marker of disease severity? Nat Rev Nephrol. 2013;9:37–50. doi:10.1038/nrneph.2012.24623165296
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Glezerman IG, Boklage SH, et al. The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients. BMC Cancer. 2016;16:564. doi:10.1186/s12885-016-2610-927473121
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Vincent M, Justice E. Diagnosis and management of hyponatremia in cancer patients. Oncologist. 2012;17:756–765. doi:10.1634/theoncologist.2011-040022618570
   PubMed Web of Science ®Google Scholar
• Abu Zeinah GF, Al-Kindi SG, Hassan AA, Allam A. Hyponatraemia in cancer: association with type of cancer and mortality. Eur J Cancer Care (Engl). 2015;24:224–231. doi:10.1111/ecc.1218724661476
   PubMed Web of Science ®Google Scholar
• Tiseo M, Buti S, Boni L, Mattioni R, Ardizzoni A. Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan. Lung Cancer. 2014;86:91–95. doi:10.1016/j.lungcan.2014.07.02225130081
   PubMed Web of Science ®Google Scholar
• Onitilo AA, Kio E, Doi SA. Tumor-related hyponatremia. Clin Med Res. 2007;5:228–237. doi:10.3121/cmr.2007.76218086907
   PubMedGoogle Scholar
• Coulson R, Seng HL, Connelly AA, et al. The Angiotensin Receptor Blocker, Losartan, Inhibits Mammary Tumor Development and Progression to Invasive Carcinoma. Vol. 8 2017:18640.
   Google Scholar
• Fried LF, Katz R, Sarnak MJ, et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol. 2005;16:3728–3735.16251239
   PubMed Web of Science ®Google Scholar
• Glezerman IG, Sternlicht H. Hypercalcemia of malignancy and new treatment options. Ther Clin Risk Manag. 2015. doi:10.2147/tcrm.S83681
   PubMed Web of Science ®Google Scholar
• Morizane S, Yumioka T, Yamaguchi N, et al. Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy. Int Urol Nephrol. 2015;47:1335–1341.26104379
   PubMed Web of Science ®Google Scholar
• Panotopoulos J, Posch F, Funovics PT, et al. Elevated serum creatinine and low albumin are associated with poor outcomes in patients with liposarcoma. J Orthop Res. 2016;34:533–538.26222652
   PubMed Web of Science ®Google Scholar